These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38788984)

  • 21. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification by tramadol of PGD
    Hioki T; Tokuda H; Tanabe K; Kim W; Tachi J; Yamaguchi S; Matsushima-Nishiwaki R; Kozawa O; Iida H
    Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102323. PubMed ID: 34392133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
    Tokuda H; Kozawa O; Uematsu T
    J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1.
    Vijayan V; Khandelwal M; Manglani K; Singh RR; Gupta S; Surolia A
    Free Radic Biol Med; 2013 Aug; 61():72-84. PubMed ID: 23500899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
    Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Kato H; Ogura S; Kozawa O
    J Bone Miner Metab; 2008; 26(4):335-41. PubMed ID: 18600399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMP-activated protein kinase positively regulates FGF-2-stimulated VEGF synthesis in osteoblasts.
    Kato K; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Natsume H; Yamakawa K; Gu Y; Otsuka T; Kozawa O
    Biochem Biophys Res Commun; 2010 Sep; 400(1):123-7. PubMed ID: 20708602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of basic fibroblast growth factor-stimulated VEGF synthesis by Wnt3a in osteoblasts.
    Tokuda H; Adachi S; Matsushima-Nishiwaki R; Kato K; Natsume H; Otsuka T; Kozawa O
    Int J Mol Med; 2011 Jun; 27(6):859-64. PubMed ID: 21399861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts.
    Yasuda E; Tokuda H; Ishisaki A; Hirade K; Kanno Y; Hanai Y; Nakamura N; Noda T; Katagiri Y; Kozawa O
    Biochem Biophys Res Commun; 2005 Mar; 328(1):137-43. PubMed ID: 15670761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
    Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
    Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
    Kuroyanagi G; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2016 Feb; 37(2):533-41. PubMed ID: 26744072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts.
    Takai S; Tokuda H; Hanai Y; Kozawa O
    Mol Cell Endocrinol; 2007 Mar; 267(1-2):46-54. PubMed ID: 17215071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
    Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2016 Apr; 13(4):3363-9. PubMed ID: 26935864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus but not cyclosporine A enhances FGF-2-induced VEGF release in osteoblasts.
    Yamauchi J; Takai S; Matsushima-Nishiwaki R; Adachi S; Minamitani C; Natsume H; Mizutani J; Otsuka T; Takeda J; Harada A; Kozawa O; Tokuda H
    Int J Mol Med; 2009 Feb; 23(2):267-72. PubMed ID: 19148552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actions of fibroblast growth factor-8 in bone cells in vitro.
    Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of AMP-activated protein kinase in thrombin-stimulated interleukin 6 synthesis in osteoblasts.
    Tokuda H; Kato K; Natsume H; Kondo A; Kuroyanagi G; Matsushima-Nishiwaki R; Ito Y; Otsuka T; Kozawa O
    J Mol Endocrinol; 2012 Aug; 49(1):47-55. PubMed ID: 22645249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress-activated protein kinase/c-Jun N-terminal kinase (JNK) plays a part in endothelin-1-induced vascular endothelial growth factor synthesis in osteoblasts.
    Wang X; Tokuda H; Hirade K; Kozawa O
    J Cell Biochem; 2002; 87(4):417-23. PubMed ID: 12397601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.